Drug Type Fusion protein |
Synonyms E-688 |
Target |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), sialic acid modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 08 May 2024 | |
Neoplasms | Preclinical | CN | 08 May 2024 |